ERIC HARMON: Open Payments
NPI 1972778934 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 78 payments from 18 companies in 2025. Trend: 2023 $2,283 · 2024 $3,431 · 2025 $1,620
Food & beverage: $1,520Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $311 |
| Amgen Inc. | 10 | $221 |
| Lilly USA, LLC | 11 | $216 |
| E.R. Squibb & Sons, L.L.C. | 4 | $181 |
| Novartis Pharmaceuticals Corporation | 6 | $138 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $127 |
| Organon LLC | 2 | $126 |
| Arcutis Biotherapeutics, Inc. | 3 | $46 |
| UCB, Inc. | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $43 |
Products named: OTEZLA, Sotyktu, RINVOQ, TALTZ, SKYRIZI, VTAMA, COSENTYX, EBGLYSS.
Industry payments across OR — which companies pay providers there.
